Project Grant HT94252410936
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$713K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Roxbury, MA 02118, USA
Similar Awards
This Project Grant award, funded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), provides $1,704,652.00 to Trustees of Boston University (Boston University Medical Campus) to conduct research on the translational impact of genetic susceptibility to complex toxic exposures on blood-brain barrier function and age-related neurological outcomes in Gulf War Illness (GWI). The award period runs from September 1, 2024 to August...
The Defense Health Agency awarded a $1,003,336 Project Grant to Trustees of Boston University under the Military Medical Research and Development program (CFDA 12.420) to investigate the "CONTRIBUTION OF CELLULAR SENESCENCE AND BRAIN AGING TO COGNITIVE DYSFUNCTION IN GWI" over a 3-year period from September 2023 to September 2026. As a leading private research institution, Boston University's Trustees will conduct biomedical research to transform healthcare for Service Members,...
This federal Project Grant award, with a funding amount of $1,155,518.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public, with a focus on innovative research addressing critical health challenges. The specific project, titled "IN VIVO NEUROEPIGENETICS IN COMBAT VETERANS WITH...
This $691,213 Project Grant from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), supports research into bioengineered 3D human brain systems to investigate risk factors, mechanisms, and treatments for traumatic brain injury-induced Alzheimer's disease. Tufts University is the primary awardee and will conduct research. Massachusetts General Hospital will provide $691,213 in research services as a sub-awardee. The overarching...
The Trustees of Boston University will receive $330,000 from the Defense Health Agency under a Project Grant award to identify receptors for TDP-43 that mediate cellular uptake and neurotoxicity. This research is being conducted under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for battlefield injuries and other health...
This $646,252 Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports research to uncover cell intrinsic and extrinsic factors governing melanoma dormancy at single-cell resolution. The primary awardee, Trustees of Boston University, will conduct this advanced biomedical research. The University of Virginia will provide academic and technical resources, including experiments generating and validating...
This $590,400 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by The Trustees of Princeton University to develop an epigenetic innate immune memory-based diagnostic biomarker signature for Gulf War Illness. The 3-year award period runs from July 1, 2025 to June 30, 2028. The project aims to investigate an "epigenetic innate immune memory hypothesis" as a potential pathophysiological...
The U.S. Defense Health Agency awarded a $817,027 Project Grant to The Roskamp Institute, Inc. in Sarasota, Florida under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant, running from August 15, 2023 to August 14, 2026, will support the institute's research on an "amnion-derived multipotent cell secretome-medicated therapy for Gulf War Illness." The Roskamp Institute is a non-profit biotechnology research organization that has previously...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $6,516,431.00 to Boston University Medical Campus to conduct research on "BRIEF CASPASE INHIBITION FOR NEUROPROTECTION IN PEDIATRIC CARDIAC SURGERY". The award period runs from August 1, 2025 to July 31, 2029. The goal of this research is to transform healthcare for military service members, veterans, and the broader public through innovative...
The Department of the Army Medical Command awarded Tufts University School of Medicine a $813,375 Project Grant through the Military Medical Research and Development program (CFDA 12.420) to investigate metabolic modulation of collagens in the extracellular matrix to preserve GABAergic inhibition after traumatic brain injury. The three-year award beginning August 1, 2022 will support research into medical solutions for traumatic brain injuries sustained on the battlefield. A $813k sub-award...